Farinati F - Search Results

1

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.

Biselli M, Conti F, Gramenzi A, Frigerio M, Cucchetti A, Fatti G, D'Angelo M, Dall'Agata M, Giannini EG, Farinati F, Ciccarese F, Andreone P, Bernardi M, Trevisani F. Biselli M, et al. Among authors: farinati f. Br J Cancer. 2015 Jan 6;112(1):69-76. doi: 10.1038/bjc.2014.536. Epub 2014 Oct 14. Br J Cancer. 2015. PMID: 25314061 Free PMC article.

2

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Farinati F, De Maria N, Fornasiero A, Salvagnini M, Fagiuoli S, Chiaramonte M, Naccarato R. Farinati F, et al. Dig Dis Sci. 1992 May;37(5):659-62. doi: 10.1007/BF01296419. Dig Dis Sci. 1992. PMID: 1373360 Clinical Trial.

3

Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.

Farinati F, Fagiuoli S, De Maria N, Chiaramonte M, Aneloni V, Ongaro S, Salvagnini M, Naccarato R. Farinati F, et al. J Hepatol. 1992 Mar;14(2-3):183-7. doi: 10.1016/0168-8278(92)90156-j. J Hepatol. 1992. PMID: 1380021

4

Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.

Naccarato R, Farinati F. Naccarato R, et al. Among authors: farinati f. Dig Dis Sci. 1991 Aug;36(8):1137-42. doi: 10.1007/BF01297461. Dig Dis Sci. 1991. PMID: 1650691 Review.

5

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.

Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R. Farinati F, et al. J Hepatol. 1990 Nov;11(3):297-301. doi: 10.1016/0168-8278(90)90211-9. J Hepatol. 1990. PMID: 1705274 Clinical Trial.

6

Hepatocellular carcinoma in primary biliary cirrhosis.

Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Farinati F, et al. J Hepatol. 1994 Sep;21(3):315-6. doi: 10.1016/s0168-8278(05)80307-1. J Hepatol. 1994. PMID: 7530737

7

CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.

Frezza EE, Gerunda GE, Farinati F, DeMaria N, Galligioni A, Plebani F, Giacomin A, Van Thiel DH. Frezza EE, et al. Among authors: farinati f. Hepatogastroenterology. 1994 Aug;41(4):367-9. Hepatogastroenterology. 1994. PMID: 7959573

8

Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.

Zaninotto M, Ujka F, Lachin M, Bernardi D, Marafi C, Farinati F, Plebani M. Zaninotto M, et al. Among authors: farinati f. Anticancer Res. 1996 Jan-Feb;16(1):305-9. Anticancer Res. 1996. PMID: 8615626

9

Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.

Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R. Farinati F, et al. Dig Dis Sci. 1996 Dec;41(12):2332-9. doi: 10.1007/BF02100123. Dig Dis Sci. 1996. PMID: 9011438

10

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Chiaramonte M, et al. Among authors: farinati f. Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page